The National Coalition for Appropriate Prescribing (led by the Prescription Project - a sister organization to us here at Prescription Access Litigation) is working to pass the Physician Payments Sunshine Act, a transparency bill requiring pharmaceutical

The unconventional thank you note: GSK exec demonstrates Yesterday Chris Viehbacher, head of GlaxoSmithKline’s U.S. Division, sent a wouldn’t-it-be-a-shame note to legislators considering a Massachusetts bill that would ban pharmaceutical vendors from giv

Courtesy of an article in The Tennessean, we just learned that WalMart has expanded $4 discount generic drug program to offer some of those same drugs for $10 for a 90-day supply. A list of the prescription drugs covered by the program can be found here.

When it comes to conflict of interest among new members of the DSM-V committee, the glass is half empty or half full, depending how you look at it. The Diagnostic and Statistical Manual for Mental Disorders is the encyclopedia of treatment guidelines put

A few weeks ago, we posted on the curious persistence – and size -- of propaganda for Vytorin, the combo cholesterol drug that’s efficacy went the way of its clinical trial results – into thin air – after a panel of cardiologists rendered its cholesterol-

Feds Put AMA on the Hot Seat This week, Senators Herb Kohl (D-WI) and Richard Durbin (D-IL) sent a letter to the American Medical Association requesting information about its prescriber data opt-out program. According to the BNA Health Care Daily Report

Sometimes the whole is not greater than the sum of the parts, just more expensive. Last week, we reported on GlaxoSmithKline's newly-approved combination drug for migraines, Treximet. ('GlaxoSmithKline sets out to dupe migraine sufferers with Treximet sm

We've written about in the past on the PAL blog about, Provigil, a prescription drug used to treat narcolepsy and other sleep conditions, which is made by Cephalon (NasdaqGS:CEPH). [See previous posts such as "FTC member speaks out on Provigil generics p

The Association of American Medical Colleges released a set of recommendations this week urging its 129 North American member medical schools to ban all industry gifts to faculty, staff and students, as well as to prohibit ghostwriting arrangements and in